TY - JOUR
T1 - Quantitative variation in vascular endothelial growth factor mRNA expression during early flexor tendon healing
T2 - An investigation in a canine model
AU - Boyer, Martin I.
AU - Watson, Jeffry T.
AU - Lou, Jueren
AU - Manske, Paul R.
AU - Gelberman, Richard H.
AU - Rong Cai, Shi
PY - 2001
Y1 - 2001
N2 - Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis, with direct mitogenic activity on cells of endothelial origin. We quantified the temporal accumulation of VEGF mRNA at the repair site of an in vivo canine intrasynovial flexor tendon repair and rehabilitation model by means of quantitative Northern blot analysis, in order to detail a molecular signal involved in the intrinsic angiogenic process that accompanies early flexor tendon healing. Significant accumulation of VEGF mRNA occurred at the flexor tendon repair site at 7 days post-operatively, with peak levels seen at post-operative days 7 and 10. Levels returned to baseline by day 14. Local VEGF mRNA accumulation at the repair site temporally precedes and is spatially distinct from the vascular ingrowth itself, which has been shown to occur maximally at day 17. These data suggest that cells within the flexor tendon repair site are involved in molecular processes other than the synthesis of extracellular matrix, such as modulation of angiogenesis.
AB - Vascular endothelial growth factor (VEGF) is a potent mediator of angiogenesis, with direct mitogenic activity on cells of endothelial origin. We quantified the temporal accumulation of VEGF mRNA at the repair site of an in vivo canine intrasynovial flexor tendon repair and rehabilitation model by means of quantitative Northern blot analysis, in order to detail a molecular signal involved in the intrinsic angiogenic process that accompanies early flexor tendon healing. Significant accumulation of VEGF mRNA occurred at the flexor tendon repair site at 7 days post-operatively, with peak levels seen at post-operative days 7 and 10. Levels returned to baseline by day 14. Local VEGF mRNA accumulation at the repair site temporally precedes and is spatially distinct from the vascular ingrowth itself, which has been shown to occur maximally at day 17. These data suggest that cells within the flexor tendon repair site are involved in molecular processes other than the synthesis of extracellular matrix, such as modulation of angiogenesis.
UR - http://www.scopus.com/inward/record.url?scp=0034858490&partnerID=8YFLogxK
U2 - 10.1016/S0736-0266(01)00017-1
DO - 10.1016/S0736-0266(01)00017-1
M3 - Article
C2 - 11562135
AN - SCOPUS:0034858490
SN - 0736-0266
VL - 19
SP - 869
EP - 872
JO - Journal of Orthopaedic Research
JF - Journal of Orthopaedic Research
IS - 5
ER -